Back to the future: Treatment-free remission and pregnancy in chronic myeloid leukemia

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

(2018) Jerald P. Radich et al.   Journal of the National Comprehensive Cancer Network

Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis

(2017) Leonardo Campiotti et al.   EUROPEAN JOURNAL OF CANCER

Management of pregnant chronic myeloid leukemia patients

(2016) Elisabetta Abruzzese et al.   Expert Review of Hematology

The impact of dasatinib on pregnancy outcomes

(2015) Jorge E. Cortes et al.   AMERICAN JOURNAL OF HEMATOLOGY

Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study

(2015) Silvia Mori et al.   AMERICAN JOURNAL OF HEMATOLOGY

Managing pregnancy in chronic myeloid leukaemia

(2015) Renuka Palani et al.   ANNALS OF HEMATOLOGY

Update on emerging treatments for chronic myeloid leukemia

(2015) Carmen Fava et al.   EXPERT OPINION ON EMERGING DRUGS

Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia

(2015) Adam M. Mendizabal et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

(2015) V S Hoffmann et al.   LEUKEMIA

Molecular monitoring in CML and the prospects for treatment-free remissions

(2015) M. W. Deininger   Hematology-American Society of Hematology Education Program

TYROSINE KINASE INHIBITORS AND PREGNANCY

(2014) Elisabetta Abruzzese et al.   Mediterranean Journal of Hematology and Infectious Diseases

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

(2013) M. Baccarani et al.   BLOOD

The effects of imatinib on pregnancy outcome

(2008) S. M. Pye et al.   BLOOD